Peptides for Men over 50
The peptides people most often research for men over 50, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 5
- With human trials
- 2
- FDA approved (any use)
- 1
- SermorelinGHRH analogHuman RCT evidence, 4 of 4The Journal of clinical endocrinology and metabolism 1992, PMID 1379256Human0Animal0Summarised2Compounded by prescriptionOverview
- IpamorelinGHRP (ghrelin receptor agonist)No study with an outcome for men over 50PubMed search, 11 Oct 2026Human0Animal0Summarised0Not FDA approved · research chemicalOverview
- BPC-157Gastric pentadecapeptideNo study with an outcome for men over 50PubMed search, 11 Oct 2026Human0Animal0Summarised0PCAC voted 8–6 for 503A (Jul 2026)Overview
- HGHRecombinant growth hormoneHuman RCT evidence, 4 of 4The Journal of clinical endocrinology and metabolism 2006, PMID 16332938Human39Animal7Summarised3FDA approved (prescription only)Overview
- CJC-1295GHRH analogNo study with an outcome for men over 50PubMed search, 11 Oct 2026Human0Animal0Summarised0Not FDA approved · research chemicalOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What trials in older men measured
PubMed records matching the site's men-over-50 search (a low-specificity population search): Sermorelin 0 human-only and 0 animal-only; Ipamorelin 0 human-only and 0 animal-only; BPC-157 0 human-only and 0 animal-only; growth hormone 39 human-only and 7 animal-only; CJC-1295 0 human-only and 0 animal-only.
Calculated from goal men-over-50; ledger date 2026-10-02; counts sermorelin (human only 0, animal 0, rct 0), ipamorelin (human only 0, animal 0, rct 0), bpc-157 (human only 0, animal 0, rct 0), hgh (human only 39, animal 7, rct 29), cjc-1295 (human only 0, animal 0, rct 0). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
In healthy old men, short-term twice-daily GHRH injections reversed age-related decreases in GH and IGF-I, and the authors suggest longer treatment could improve body composition.[1]
A later trial of nightly GHRH in healthy elderly men found no change in weight, DEXA muscle and fat, glucose, insulin or lipids.[18]
Two of six strength measures (upright row and shoulder press) and an abdominal-crunch endurance test improved in that trial.[18]
In a randomized trial of growth hormone with or without testosterone in healthy older men, muscle strength changes were variable, with one of six measures improving on the combination.[2]
Common questions
Does sermorelin work for men over 50?
The cached human studies of GHRH in older men report GH and IGF-I levels, and a nightly-GHRH trial found no change in DEXA measures of muscle and fat.[18]
Explore nearby goals
Sources
- 1Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
- 2The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.The Journal of clinical endocrinology and metabolism · 2006PMID 16332938Accessed 2 Oct 2026
- 3PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: "BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab] (230 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: "BPC-157"[tiab] AND humans[mh] (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (patients[tiab] OR clinical trial[pt] OR randomized[tiab]) (25 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (colitis[tiab] OR inflammatory bowel[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (tendon[tiab] OR ligament[tiab] OR muscle[tiab] OR bone[tiab] OR arthritis[tiab]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (nerve[tiab] OR neuropath*[tiab] OR spinal[tiab] OR liver[tiab] OR wound[tiab] OR burn[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) (33 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: ipamorelin[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 15PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (57 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 16PubMed search: ("BPC-157"[tiab] OR "BPC 157"[tiab]) AND (human[tiab] OR patient*[tiab] OR volunteer*[tiab]) AND (adverse[tiab] OR safety[tiab] OR "side effects"[tiab]) (19 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 17PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 18Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism: clinical and experimental · 1997PMID 9005976Accessed 2 Oct 2026
Found an error? Report a correction.